| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TuHURA Biosciences, Inc./NV | Chief Financial Officer | Options (Right to Buy) | 273,696 | 06 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HURA | TuHURA Biosciences, Inc./NV | 06 Jan 2026 | 1 | $0 | 4 | Chief Financial Officer | 08 Jan 2026, 16:35 |
| HURA | TuHURA Biosciences, Inc./NV | 12 Dec 2025 | 1 | $0 | 4 | Chief Financial Officer | 17 Dec 2025, 06:37 |
| HURA | TuHURA Biosciences, Inc./NV | 12 Nov 2024 | 1 | $0 | 4 | Chief Financial Officer | 14 Nov 2024, 16:46 |
| KTRA | Kintara Therapeutics, Inc. | 18 Oct 2024 | 5 | $0 | 4 | Chief Financial Officer | 22 Oct 2024, 20:01 |
| KTRA | Kintara Therapeutics, Inc. | 18 Oct 2024 | 0 | $0 | 3 | Chief Financial Officer | 22 Oct 2024, 19:56 |